Geron Corporation - stock earnings

GERN Upcoming estimated earnings

Date Actual / Estimated EPS Low Revenue Actual / Estimated Revenue High Revenue
May 2, 2024 AfterMarket -0.09 / -0.10 - 300000 / 29406 -

GERN Quarterly earnings

DateEarningsRevenue
2023Q4 -52.0 million USD 23000 USD
2023Q3 -44.8 million USD 164000 USD
2023Q2 -49.2 million USD 29000 USD
2023Q1 -38.1 million USD 21000 USD
2022Q4 -42.4 million USD 103000 USD
2022Q3 -40.8 million USD 297000 USD
2022Q2 -28.3 million USD 73000 USD
2022Q1 -31.5 million USD 123000 USD
2021Q4 -32.0 million USD 1.0 million USD
2021Q3 -26.7 million USD 109000 USD
2021Q2 -29.6 million USD 107000 USD
2021Q1 -27.8 million USD 137000 USD
2020Q4 -23.8 million USD 50000 USD
2020Q3 -19.7 million USD 108000 USD
2020Q2 -15.8 million USD 43000 USD
2020Q1 -16.4 million USD 52000 USD
2019Q4 -29.1 million USD 171000 USD
2019Q3 -15.2 million USD 131000 USD
2019Q2 -14.2 million USD 101000 USD
2019Q1 -10.1 million USD 57000 USD
2018Q4 -7.3 million USD 375000 USD
2018Q3 -5.6 million USD 165000 USD
2018Q2 -6.9 million USD 208000 USD
2018Q1 -7.2 million USD 318000 USD
2017Q4 -7.4 million USD 191000 USD
2017Q3 -6.9 million USD 163000 USD
2017Q2 -6.4 million USD 174000 USD
2017Q1 -7.2 million USD 537000 USD
2016Q4 -8.5 million USD 94000 USD
2016Q3 -3.6 million USD 5.1 million USD
2016Q2 -8.6 million USD 211000 USD
2016Q1 -8.8 million USD 749000 USD
2015Q4 -8.5 million USD 220000 USD
2015Q3 27.2 million USD 35.4 million USD
2015Q2 -9.4 million USD 251000 USD
2015Q1 -9.3 million USD 537000 USD
2014Q4 -8.9 million USD 178000 USD
2014Q3 -9.5 million USD 160000 USD
2014Q2 -8.7 million USD 341000 USD
2014Q1 -8.4 million USD 474000 USD
2013Q4 -9.3 million USD 225000 USD
2013Q3 -8.3 million USD 181000 USD
2013Q2 -8.9 million USD 112000 USD
2013Q1 -11.9 million USD 765000 USD
2012Q4 -15.9 million USD 689000 USD
2012Q3 -16.0 million USD 636000 USD
2012Q2 -18.3 million USD 130000 USD
2012Q1 -18.7 million USD 1.3 million USD
2011Q4 -31.9 million USD 251000 USD
2011Q3 -19.5 million USD 220000 USD
2011Q2 -21.1 million USD 462000 USD
2011Q1 -24.4 million USD 1.5 million USD
2010Q4 -59.4 million USD 1.1 million USD
2010Q3 -18.3 million USD 546000 USD
2010Q2 -17.0 million USD 1.0 million USD
2010Q1 -16.6 million USD 918000 USD
2009Q4 -18.4 million USD 605000 USD
2009Q3 -15.2 million USD 494000 USD
2009Q2 -19.8 million USD 183000 USD
2009Q1 -16.8 million USD 444000 USD
2008Q4 -17.6 million USD 544000 USD
2008Q3 -17.2 million USD 367000 USD
2008Q2 -13.6 million USD 198000 USD
2008Q1 -13.7 million USD 1.7 million USD
2007Q4 -11.0 million USD 4.7 million USD
2007Q3 -12.8 million USD 1.1 million USD
2007Q2 -14.0 million USD 889000 USD
2007Q1 1.2 million USD 916000 USD
2006Q4 -3.3 million USD 1.2 million USD
2006Q3 -9.8 million USD 723000 USD
2006Q2 -9.3 million USD 786000 USD
2006Q1 -9.0 million USD 583000 USD
2005Q4 -8.9 million USD -5.1 million USD
2005Q3 -11.9 million USD 673000 USD
2005Q2 -3.1 million USD 4.7 million USD
2005Q1 -9.7 million USD 59000 USD
2004Q4 -9.5 million USD 338000 USD
2004Q3 -10.3 million USD 101000 USD
2004Q2 -8.9 million USD 366000 USD
2004Q1 -51.7 million USD 248000 USD
2003Q4 -7.6 million USD 155000 USD
2003Q3 -5.1 million USD 472000 USD
2003Q2 -9.3 million USD 285000 USD
2003Q1 -7.9 million USD 36000 USD
2002Q4 -7.2 million USD 293000 USD
2002Q3 -7.2 million USD 218000 USD
2002Q2 -9.0 million USD 111000 USD
2002Q1 -10.5 million USD 515000 USD
2001Q4 -19.4 million USD 623000 USD
2001Q3 -9.1 million USD 615000 USD
2001Q2 -6.1 million USD 585000 USD
2001Q1 -7.4 million USD 1.8 million USD
2000Q4 -15.9 million USD 1.8 million USD
2000Q3 -4.9 million USD 1.8 million USD
2000Q2 -16.5 million USD 1.8 million USD
2000Q1 -6.6 million USD 1.3 million USD
1999Q4 -8.1 million USD 1.3 million USD
1999Q3 -6.9 million USD 1.3 million USD
1999Q2 -28.0 million USD 1.3 million USD
1999Q1 -3.3 million USD 1.5 million USD
1998Q4 -3.7 million USD 1.5 million USD
1998Q3 -2.8 million USD 1.5 million USD
1998Q2 -2.4 million USD 1.5 million USD
1998Q1 -1.9 million USD 2.3 million USD
1997Q4 -1.4 million USD 2.8 million USD
1997Q3 -2.0 million USD 2.2 million USD
1997Q2 -1.8 million USD 2.2 million USD
1997Q1 -4.4 million USD 100000 USD
1996Q4 -3.1 million USD 900000 USD
1996Q3 -2.7 million USD 1.5 million USD
1996Q2 -2.5 million USD 1.6 million USD
1996Q1 -2.4 million USD 1.3 million USD

GERN Yearly earnings

DateEarningsRevenue
2023 -184.1 million USD 237000 USD
2022 -141.0 million USD 596000 USD
2021 -121.0 million USD 1.4 million USD
2020 -75.6 million USD 253000 USD
2019 -63.6 million USD 460000 USD
2018 -27.0 million USD 1.1 million USD
2017 -27.9 million USD 1.1 million USD
2016 -29.5 million USD 6.2 million USD
2015 46000 USD 36.4 million USD
2014 -35.7 million USD 1.2 million USD
2013 -38.4 million USD 1.3 million USD
2012 -68.9 million USD 2.7 million USD
2011 -96.9 million USD 2.4 million USD
2010 -111.4 million USD 3.6 million USD
2009 -70.2 million USD 1.7 million USD
2008 -62.0 million USD 2.8 million USD
2007 -36.7 million USD 7.6 million USD
2006 -31.4 million USD 3.3 million USD
2005 -33.5 million USD 290000 USD
2004 -80.4 million USD 1.1 million USD
2003 -29.9 million USD 1.2 million USD
2002 -33.9 million USD 1.2 million USD
2001 -42.1 million USD 3.6 million USD
2000 -45.8 million USD 6.6 million USD
1999 -46.4 million USD 5.4 million USD
1998 -10.8 million USD 6.8 million USD
1997 -9.6 million USD 7.3 million USD
1996 -10.7 million USD 5.3 million USD

GERN

Price: $3.93

52 week price:
1.64
4.14

Earnings Per Share: -0.32 USD

P/E Ratio: -5.56

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 535483

Ebitda: -6.9 million

Market Capitalization: 2.0 billion

Links: